119 related articles for article (PubMed ID: 34953019)
1. Osteosarcoma cells in early and late stages as cancer in vitro progression model for assessing the responsiveness of cells to silver nanoparticles.
Sokołowska P; Siatkowska M; Białkowska K; Rosowski M; Komorowski P; Walkowiak B
J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1319-1334. PubMed ID: 34953019
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Response of HOS and Saos-2 Osteosarcoma Cell Lines When Exposed to Different Sizes and Concentrations of Silver Nanoparticles.
Michalakis K; Bakopoulou A; Papachristou E; Vasilaki D; Tsouknidas A; Michailidis N; Johnstone E
Biomed Res Int; 2021; 2021():5013065. PubMed ID: 34938808
[TBL] [Abstract][Full Text] [Related]
3. Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis.
Kovács D; Igaz N; Keskeny C; Bélteky P; Tóth T; Gáspár R; Madarász D; Rázga Z; Kónya Z; Boros IM; Kiricsi M
Sci Rep; 2016 Jun; 6():27902. PubMed ID: 27291325
[TBL] [Abstract][Full Text] [Related]
4. Silver nanoparticle toxicity in silkworms: Omics technologies for a mechanistic understanding.
Chen L; Meng X; Gu J; Fan W; Abdlli N; Peprah FA; Wang N; Zhu F; Lü P; Ma S; Chen K
Ecotoxicol Environ Saf; 2019 May; 172():388-395. PubMed ID: 30731270
[TBL] [Abstract][Full Text] [Related]
5. Proteomics study of silver nanoparticles on Caco-2 cells.
Gioria S; Urbán P; Hajduch M; Barboro P; Cabaleiro N; La Spina R; Chassaigne H
Toxicol In Vitro; 2018 Aug; 50():347-372. PubMed ID: 29626626
[TBL] [Abstract][Full Text] [Related]
6. Altered morphology, nuclear stability and adhesion of highly metastatic derivatives of osteoblast-like SAOS-2 osteosarcoma cells.
Muff R; Nigg N; Gruber P; Walters D; Born W; Fuchs B
Anticancer Res; 2007; 27(6B):3973-9. PubMed ID: 18225558
[TBL] [Abstract][Full Text] [Related]
7. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK.
Hu XK; Rao SS; Tan YJ; Yin H; Luo MJ; Wang ZX; Zhou JH; Hong CG; Luo ZW; Du W; Wu B; Yan ZQ; He ZH; Liu ZZ; Cao J; Wang Y; Situ WY; Liu HM; Huang J; Wang YY; Xia K; Qian YX; Zhang Y; Yue T; Liu YW; Zhang HQ; Tang SY; Chen CY; Xie H
Theranostics; 2020; 10(17):7710-7729. PubMed ID: 32685015
[TBL] [Abstract][Full Text] [Related]
8. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
Wang GW; Guo W; Tang XD; Peng CL; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
[TBL] [Abstract][Full Text] [Related]
9. Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture system.
Arai K; Sakamoto R; Kubota D; Kondo T
Proteomics; 2013 Aug; 13(15):2351-60. PubMed ID: 23712969
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered silver nanoparticles capped with bovine serum albumin and its anticancer and apoptotic activity against breast, bone and intestinal colon cancer cell lines.
Majeed S; Aripin FHB; Shoeb NSB; Danish M; Ibrahim MNM; Hashim R
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():254-263. PubMed ID: 31146998
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytotoxicity and genotoxicity effects of silver nanoparticles on human cervix and breast cancer cell lines.
Juarez-Moreno K; Gonzalez EB; Girón-Vazquez N; Chávez-Santoscoy RA; Mota-Morales JD; Perez-Mozqueda LL; Garcia-Garcia MR; Pestryakov A; Bogdanchikova N
Hum Exp Toxicol; 2017 Sep; 36(9):931-948. PubMed ID: 27815378
[TBL] [Abstract][Full Text] [Related]
12. Silver nanoparticle-induced expression of proteins related to oxidative stress and neurodegeneration in an in vitro human blood-brain barrier model.
Khan AM; Korzeniowska B; Gorshkov V; Tahir M; Schrøder H; Skytte L; Rasmussen KL; Khandige S; Møller-Jensen J; Kjeldsen F
Nanotoxicology; 2019 Mar; 13(2):221-239. PubMed ID: 30623748
[TBL] [Abstract][Full Text] [Related]
13. Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics.
Kikuta K; Tochigi N; Saito S; Shimoda T; Morioka H; Toyama Y; Hosono A; Suehara Y; Beppu Y; Kawai A; Hirohashi S; Kondo T
Proteomics Clin Appl; 2010 May; 4(5):560-7. PubMed ID: 21137073
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
Li Y; Hou H; Zhang P; Zhang Z
Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
[TBL] [Abstract][Full Text] [Related]
15. Death and cell cycle progression are differently conditioned by the AgNP size in osteoblast-like cells.
Rosário F; Hoet P; Santos C; Oliveira H
Toxicology; 2016 Aug; 368-369():103-115. PubMed ID: 27590928
[TBL] [Abstract][Full Text] [Related]
16. Protein corona on biogenic silver nanoparticles provides higher stability and protects cells from toxicity in comparison to chemical nanoparticles.
Spagnoletti FN; Kronberg F; Spedalieri C; Munarriz E; Giacometti R
J Environ Manage; 2021 Nov; 297():113434. PubMed ID: 34400389
[TBL] [Abstract][Full Text] [Related]
17. Shape-Depended Biological Properties of Ag
Steckiewicz KP; Zwara J; Jaskiewicz M; Kowalski S; Kamysz W; Zaleska-Medynska A; Inkielewicz-Stepniak I
Oxid Med Cell Longev; 2019; 2019():6740325. PubMed ID: 31827692
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Ludartin on Cell Proliferation, Cell Migration, Cell Cycle Arrest and Apoptosis Are Associated with Upregulation of p21WAF1 in Saos-2 Osteosarcoma Cells In Vitro.
Zhang SL; Li BL; Li W; Lu M; Ni LY; Ma HL; Meng QG
Med Sci Monit; 2018 Jul; 24():4926-4933. PubMed ID: 30008466
[TBL] [Abstract][Full Text] [Related]
19. Effect of human granulocyte macrophage-colony stimulating factor on differentiation and apoptosis of the human osteosarcoma cell line SaOS-2.
Postiglione L; Di Domenico G; Giordano-Lanza G; Ladogana P; Turano M; Castaldo C; Di Meglio F; Cocozza S; Montagnani S
Eur J Histochem; 2003; 47(4):309-16. PubMed ID: 14706926
[TBL] [Abstract][Full Text] [Related]
20. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1.
Li S; Pei Y; Wang W; Liu F; Zheng K; Zhang X
Biomed Pharmacother; 2019 Jun; 114():108839. PubMed ID: 30978523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
